Bridger Management’s Immunogen Inc IMGN Stock Holding History

Bridger Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-467,220	Closed	-$7.41M	–	42
2023 Q3	$7.41M	Hold	467,220	–	–	2.72%	16
2023 Q2	$8.82M	Buy	+467,220	New	+$5.52M	2.92%	16
2022 Q3	–	Sell	-278,000	Closed	-$1.25M	–	49
2022 Q2	$1.25M	Sell	278,000 -224,000	-45%	-$973K	0.28%	37
2022 Q1	$2.39M	Buy	+502,000	New	+$2.78M	0.39%	42

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bridger Management's IMGN Position: Q4 2023 in Review

Bridger Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 467,220 shares — an estimated $7.41M sold.

Bridger Management first reported a position in IMGN in Q1 2022 and held it in 4 quarters. The position peaked at $8.82M in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

Bridger Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
Bridger Management sold 467,220 Immunogen Inc shares in Q4 2023, an estimated $7.41M.
Bridger Management first reported a position in Immunogen Inc in Q1 2022 and held it in 4 quarters.
Bridger Management's Immunogen Inc position peaked at $8.82M in Q2 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Bridger Management's 13F filing for Q4 2023, filed 14 Feb 2024.